United States v. Yosany Sosa

777 F.3d 1279, 2015 WL 412323
CourtCourt of Appeals for the Eleventh Circuit
DecidedFebruary 2, 2015
Docket13-13171
StatusPublished
Cited by117 cases

This text of 777 F.3d 1279 (United States v. Yosany Sosa) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Yosany Sosa, 777 F.3d 1279, 2015 WL 412323 (11th Cir. 2015).

Opinion

HULL, Circuit Judge:

After a jury trial, Yosany Sosa appeals his convictions for one count of conspiracy to commit health care fraud, in violation of 18 U.S.C. §§ 1349 and 1347; eight counts of health care fraud, in violation of 18 U.S.C. § 1347; one count of conspiracy to pay health care kickbacks, in violation of 18 U.S.C. §§ 371 and 1320a-7b(b)(2)(A); and three counts of payment of kickbacks in connection with a federal health care program, in violation of 42 U.S.C. § 1320a-7b(b)(2)(A). Sosa also appeals his total 102-month sentence. Sosa contends that the government failed to introduce evidence to sustain his convictions, that the prosecution’s closing statements amounted to misconduct requiring reversal, and that the district court erred in calculating his advisory sentencing guidelines range. After a careful review of the record and the briefs, and with the benefit of oral argu *1286 ment, we affirm Sosa’s convictions and sentence.

I. BACKGROUND

On March 29, 2012, a federal grand jury returned a 15-count indictment against defendant-appellant Sosa and Arsenio Leon. The indictment charged Sosa and Leon each with one count of conspiracy to commit health care fraud, eight counts of health care fraud, one count of conspiracy to pay health care kickbacks, and five counts of payment of kickbacks in connection with a federal health care program. The kickback counts specifically alleged that Sosa and Leon paid kickbacks of $1,550 on or around May 21, 2011; $2,200 on or around June 28, 2011; $2,250 on or around July 11, 2011; $2,400 on or around August 1, 2011; and $2,400 on or around August 8, 2011. Sosa and Leon each pleaded not guilty, and the pair was tried jointly.

Because Sosa challenges, inter alia, the sufficiency of the evidence, we begin by recounting the evidence presented at trial relating to his convictions.

A. Evidence Presented at Trial 1

On May 31, 2002, Leon incorporated Discovery Therapy, Inc. (“Discovery”). Nearly nine years later, on April 21, 2011, Leon opened a bank account for Discovery at J.P. Morgan Chase and hired a company named DNA Billing to prepare Medicare claims for Discovery. On April 25, 2011, Discovery applied to become an authorized provider of Medicare Part C services through Blue Cross Blue Shield (“BCBS”), which administers the Medicare Part C program.

Discovery eventually became a licensed Medicare Part C provider, and listed itself as a “convenient care center,” which is a clinic designed to provide physical examinations, injections, and treatment for non-serious illnesses. 2 In connection with Discovery’s licensing as a Medicare Part C provider, Leon filed an authorization agreement with BCBS, which stated that all Medicare claim payments made to Discovery should be directly deposited into the J.P. Morgan Chase bank account that Leon opened on April 21, 2011.

Beginning on May 30, 2011, Discovery began to submit Medicare Part C claims to BCBS. On June 29, 2011, while Discovery continued to submit Medicare claims to BCBS, Leon added Sosa as an authorized signatory on Discovery’s J.P. Morgan Chase bank account. Sosa had invested $10,000 in Discovery and had become a partner in the enterprise.

Sosa and Leon eventually withdrew about $119,000 each from Discovery’s bank account. Sosa’s withdrawals included $30,000 in checks written to Y&R Medical Center Group, a company Sosa created but never opened, while the rest of Sosa’s profits were distributed directly to him.

Between May 30, 2011 and August 19, 2011, Discovery ostensibly served as a community health clinic and provided treatment for 12 Medicare Part C patients for whom it billed BCBS. Nearly all the Medicare Part C claims Discovery submitted to BCBS were fraudulent because they were for pharmaceutical injections and infusions that Discovery’s patients did not receive.

*1287 Discovery implemented its fraud scheme as follows. The clinic hired an individual named Miguel Angel Milian Martinez 3 to recruit patients who would seek medical services at Discovery. Milian Martinez found, recruited, and paid individuals who were HIV-positive or suffering from AIDS to come to the clinic for so-called treatments. These “patients” would receive “treatment” in the form of vitamin shots or protein injections. However, Discovery would then submit Medicare claims to BCBS indicating that these patients had received doses of expensive drugs, frequently octreotide depot. But Discovery never even purchased octreotide depot, let alone provided patients with injections of the drug.

For example, Discovery paid Edward Caldero $450 to $500 in cash every week for approximately three months to be a “patient” at the clinic. Although Discovery submitted claims stating that Caldero had received 12 injections of octreotide depot in July 2011 — including three injections all on July 1, 2011, and another three injections on July 15, 2011 — Caldero never received octreotide depot injections or received three injections of any substance on any single day. Instead of receiving octreotide, Caldero received injections of Vitamin C or Vitamin B-12. After receiving his injections, Caldero would “wait around” Discovery’s offices for a while before someone would “take [him] to the side and slip [him] the money” he was promised. Although Sosa never personally paid Caldero, Caldero testified that Sosa hung around the clinic, transported patients to and from Discovery’s offices, and even gave Caldero rides at times. In sum, Discovery billed $143,450.65 for Caldero’s “treatment,” and BCBS paid Discovery $90,701.20 for services purportedly rendered to Caldero.

Similarly, Discovery paid Gustov Llerena, an HIV-positive patient suffering from AIDS and affected by bipolar disorder, $150 a week for three to four weeks to go to Discovery for “treatment for neuropathy.” However, when he went to the clinic, Llerena received only shots of Vitamin B-12. Llerena never received infusions of any drug during his visits to Discovery, and he never received more than one injection per visit. But Discovery submitted claims to BCBS that indicated Llerena had received multiple injections and infusions on single days, including on June 3, 2011, June 6, 2011, and June 10, 2011. Llerena stopped going to Discovery after he realized that “there was no treatment” and an individual working at Discovery wrongly informed him that he had syphilis. When asked to identify anyone he knew to be associated with the clinic, Llerena identified Sosa.

Another former patient at Discovery, Kenneth Mackens, went to the clinic one to three times a week for six weeks in 2011.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Sherley Beaufils
Eleventh Circuit, 2025
Jason Hartman v. Charles Sells
Eleventh Circuit, 2025
United States v. Nelly Anderson
Eleventh Circuit, 2025
Stone v. United States
M.D. Florida, 2024
United States, Ex Rel. Hart v. McKesson Corp.
96 F.4th 145 (Second Circuit, 2024)
United States v. Eric Lamar White
Eleventh Circuit, 2023
United States v. Tyvonne Wiley
78 F.4th 1355 (Eleventh Circuit, 2023)
United States v. John Gladden
78 F.4th 1232 (Eleventh Circuit, 2023)
United States v. Perez Soto
80 F.4th 50 (First Circuit, 2023)
United States v. Jim C. Beck
Eleventh Circuit, 2023
United States v. Mack Doak
47 F.4th 1340 (Eleventh Circuit, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
777 F.3d 1279, 2015 WL 412323, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-yosany-sosa-ca11-2015.